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Activity-dependent neurotransmitter switching en-
gages genetic programs regulating transmitter
synthesis, but the mechanism by which activity is
transduced is unknown. We suppressed activity in
single neurons in the embryonic spinal cord to deter-
mine whether glutamate-gamma-aminobutyric acid
(GABA) switching is cell autonomous. Transmitter
respecification did not occur, suggesting that it is
homeostatically regulated by the level of activity
in surrounding neurons. Graded increase in the num-
ber of silenced neurons in cultures led to graded
decrease in the number of neurons expressing
GABA, supporting non-cell-autonomous transmitter
switching. We found that brain-derived neurotrophic
factor (BDNF) is expressed in the spinal cord during
the period of transmitter respecification and that
spike activity causes release of BDNF. Activation of
TrkB receptors triggers a signaling cascade involving
JNK-mediated activation of cJun that regulates tlx3, a
glutamate/GABA selector gene, accounting for cal-
cium-spike BDNF-dependent transmitter switching.
Our findings identify a molecular mechanism for ac-
tivity-dependent respecification of neurotransmitter
phenotype in developing spinal neurons.
INTRODUCTION
Specification of neurotransmitters is a fundamental aspect
of neuronal development, allowing establishment of functional
connections at synapses and enabling normal operation of the
nervous system. Distinct expression patterns of transmitters are
initially determined by transcription factors via genetic programs
(Cheng et al., 2004; Mizuguchi et al., 2006; Pillai et al., 2007) and
subsequently respecified by electrical activity (Dulcis andSpitzer,
2008; Demarque and Spitzer, 2010; Marek et al., 2010). Activity-
dependent transmitter respecification is a recently discovered
form of brain plasticity, distinct from changes in synaptic strength
and number of synapses, in which neurons acquire an additional
transmitter, lose a transmitter, or switch between one transmitter
andanother (Spitzer, 2012). It canbedrivenby target-derived fac-1004 Neuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc.tors, experimental manipulations of spontaneous activity, or by
natural fluctuations in sensory stimuli in both developing and
mature neurons (Furshpan et al., 1976; Landis, 1976; Walicke
et al., 1977; Schotzinger and Landis, 1988; Gutie´rrez, 2002; Bor-
odinsky et al., 2004; Dulcis and Spitzer, 2008; Demarque
andSpitzer, 2010;Marek et al., 2010; Dulcis et al., 2013). Sponta-
neous Ca2+ spikes regulate inhibitory and excitatory transmitter
phenotypes homeostatically in embryonic Xenopus spinal neu-
rons. When Ca2+ spikes are suppressed, more neurons express
the excitatory neurotransmitters glutamate and acetylcholine.
In contrast, when Ca2+ spiking is increased, more neurons ex-
press the inhibitory neurotransmitters gamma-aminobutyric
acid (GABA) andglycine (Borodinskyet al., 2004).Herewe identify
thesignal transductioncascade linkingactivity to changes ingene
expression that lead to transmitter switching.
Electrical activity leads to a wide range of elevations of intra-
cellular Ca2+ that could regulate expression of genes deter-
mining excitatory or inhibitory phenotype in a cell-autonomous
manner. However, these transient elevations of intracellular
Ca2+ could also regulate cellular secretion enabling inductive
interactions among cells to specify neurotransmitter via a non-
cell-autonomous mechanism (Spitzer, 2006). The role of cell-
autonomous versus non-cell-autonomous mechanisms is often
examined in purified and sparsely plated cultures (Tonge and
Andrews, 2010), but is more challenging to address in vivo
(Lee and Luo, 1999; Zong et al., 2005). We address this issue
by developing a single-neuron targeting method in vivo. No
transmitter switch was observed in single neurons in which
Ca2+ spikes had been suppressed, indicating that a non-cell-
autonomous mechanism is involved.
Brain-derived neurotrophic factor (BDNF) then became an
attractive candidate to regulate activity-dependent transmitter re-
specification because its expression and release are regulated by
neuronal activity (Balkowiec and Katz, 2002; Ga¨rtner and Staiger,
2002; Tabuchi et al., 2000), and it has been implicated in mecha-
nisms that optimize neuronal differentiation and neuronal plas-
ticity (Vicario-Abejo´net al., 2002;ParkandPoo,2013).Application
or overexpression of BDNF promotes development of inhibition
(Ohba et al., 2005), whereas decreased expression or disruption
of the function of BDNF impairs development of inhibitory synap-
ses (Hong et al., 2008; Shinoda et al., 2011). On the other hand,
application of BDNF leads to suppression of excitatory synaptic
transmission (Yanget al., 2002). BDNFexerts its actionbybinding
preferentially to its tyrosine receptor kinase (TrkB) but also
through its low-affinity receptor p75. Upon ligand binding, TrkB
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BDNF-Dependent Transmitter Respecificationreceptor dimerization leads to trans-autophosphorylation and
activation of intracellular signaling cascades, including MAP ki-
nase (MAPK), PI 3-kinase (PI3K), and phospholipase-Cg (PLCg)
pathways (Huang and Reichardt, 2003).
We demonstrate Ca2+ spike-dependent BDNF release, iden-
tify critical components of the molecular signaling pathway
downstream of BDNF, and show that BDNF regulates gluta-
mate/GABA switching. Thus, genetic programs and collective
electrical activity that drives transmitter induction via BDNF
determine the mature transmitter phenotype. Understanding
the molecular basis of transmitter respecification identifies po-
tential points of intervention for therapeutically enhancing or
restoring synaptic transmission that is impaired in neurological
or psychiatric disorders.
RESULTS
Suppression of Ca2+ Spike Activity in Single Neurons
In Vivo
Ca2+-dependent electrical activity in embryonic Xenopus spinal
neurons homeostatically regulates respecification of the neuro-
transmitters that neurons express without affecting cell identities
both in vivo and in vitro (Borodinsky et al., 2004). Misexpression
of human inward rectifier K+ channels (hKir2.1) by injection of
hKir2.1 mRNA causes more neurons to express the excitatory
transmitters glutamate and acetylcholine, while fewer neurons
express the inhibitory transmitters GABA and glycine in the spi-
nal cord. We developed a single-neuron targeting system to
determine whether activity-dependent neurotransmitter respeci-
fication is cell autonomous in vivo. Expression from DNA con-
structs is mosaic and only a few cells express large amounts
of transcript whereas most cells express none (Kroll and Amaya,
1996). Accordingly, blastomeres were injected with hKir2.1 DNA
instead of mRNA. Although mosaic expression from DNA con-
structs has been regarded as a nuisance, here it becomes an
asset. In addition, neuronal lineages have been determined at
the 16-cell stage (Moody, 1989), enabling more specific manip-
ulation of Ca2+ spike activity in particular classes of spinal neu-
rons. We thus performed injections at this stage to further limit
the number of cells expressing the DNA of interest.
We injected hKir2.1-mCherry DNA into the D1.1 or D1.2 blas-
tomeres of the 16-cell blastula (Figure S1A available online), both
of which make a major contribution to neurons in the ventral spi-
nal cord (http://www.xenbase.org). When embryos reached the
late tailbud stage (stage 41), mCherry was typically observed
in several neurons separated along the spinal cord (Figure S1B),
indicating the success of targeting single neurons by this
method. Eighty percent were located on the ventral side of the
neural tube and only 20% were located on the dorsal side of
the neural tube (Figure S1C). Because V1.2 blastomeres make
a major contribution to the dorsal spinal cord (http://www.
xenbase.org), DNA injection of these cells predominantly tar-
geted neurons on the dorsal side (data not shown).
Activity Blockade in Single Neurons Does Not Switch
Neurotransmitters
hKir2.1 has been used to suppress neuronal excitability both
in vitro (Burrone et al., 2002) and in vivo (Borodinsky et al.,2004; Mizuno et al., 2007). To determine whether misexpression
of hKir2.1-mCherry in single neurons suppresses Ca2+ spikes,
we assessed Ca2+ activity in these mCherry-labeled neurons
by confocal imaging of Fluo-4 AM. Although neurons located
on both dorsal and ventral surfaces spike in situ in X. laevis, those
positioned on the dorsal surface spike at lower frequencies at
early stages of development (Belgacem and Borodinsky, 2011;
Borodinsky et al., 2004; Gu et al., 1994; Root et al., 2008). We
thus imaged the intact ventral spinal cord at stage 23-25 when
most classes of neurons exhibit a higher incidence and fre-
quency of Ca2+ spikes (Borodinsky et al., 2004). Neurons without
hKir2.1 expression in the same embryos served as internal con-
trols (Figure 1A). Misexpression of hKir2.1-mCherry decreased
both spike incidence and frequency in single neurons (Figures
1B and 1C; Figure S1D). The incidence and frequency of spiking
in single neurons expressingmCherry alonewere similar to those
in internal controls, suggesting that mCherry has no effect on
Ca2+ spike activity and allows hKir2.1 to effectively exert its
hyperpolarizing function (Figure 1C; Figure S1D).
We then determined whether homeostatic transmitter switch-
ing occurred in the single neurons in which Ca2+ spike activity
had been suppressed. The primary nervous system in Xenopus
embryos is composed of 1,000 neurons (Hartenstein, 1993).
Neurons on the ventral side of the neural tube include cholinergic
motor neurons, GABAergic ascending interneurons, and cholin-
ergic/glutamatergic descending interneurons (Li et al., 2004;
Roberts et al., 1987). Neurons on the dorsal side of the neural
tube comprise the glutamatergic Rohon-Beard sensory neurons
and GABAergic/glycinergic dorsolateral ascending interneurons
(Roberts et al., 1987; Sillar and Roberts, 1988). If Ca2+ spikes
acted cell autonomously, we expected that suppressing activity
in single neurons on the ventral side of the spinal cord would
cause neurons not normally glutamatergic to acquire a glutama-
tergic phenotype, identified by expression of vesicular glutamate
transporter (vGluT1). VGluT1-, but not vGluT2- or vGluT3-immu-
noreactivity, colocalizes with glutamate immunoreactivity (Glu-
IR), making vGluT1 a useful glutamatergic marker (Borodinsky
et al., 2004). In parallel, we expected that suppressing activity
in single neurons on the dorsal side of the spinal cord would
cause them to lose the GABAergic phenotype, assessed by
GABA-immunoreactivity (GABA-IR). Neurons were identified by
position and morphology. Strikingly, the incidence of vGluT1-
IR neurons among hKir2.1-mCherry-labeled ventral neurons
and amongmCherry-alone-labeled ventral neurons did not differ
from each other. This result indicates that the glutamatergic
phenotype was not acquired in single neurons in which Ca2+
spikes had been suppressed (Figure 1D). Moreover, no differ-
ence was observed in the incidence of GABA-IR between
hKir2.1-mCherry-labeled neurons and mCherry-alone-labeled
dorsal neurons, indicating that there is no decrease in the inci-
dence of GABA-IR cells among the single neurons in which
Ca2+ spikes have been suppressed (Figure 1E). These data sug-
gest that the mechanism for Ca2+ spike activity-dependent
transmitter respecification in the embryonic spinal cord is non-
cell autonomous.
To further analyze network-dependent regulation of trans-
mitter switching, we changed the ratio of silenced to unsilenced
neurons in a graded manner. Because most chemical synapsesNeuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc. 1005
Figure 1. Misexpression of hKir2.1 Sup-
presses Ca2+ Spike Generation in Single
Neurons In Situ without Changing the Iden-
tity of Their Neurotransmitter
(A) Confocal image of a stage 25 ventral spinal
cord. Dashed oval outlines a hKir2.1-mCherry/
Fluo-4 AM-expressing neuron (red and yellow).
Neurons loaded with Fluo-4 AM (green) are internal
controls.
(B) Spike activity is absent in these hKir2.1-
mCherry-expressingneurons andpresent in internal
controls. Ca2+ spikes were identified as fluores-
cence transients greater than20%ofDF/F0 (dashed
lines), more than twice the SD of the baseline.
(C) Spike incidence during 1 hr imaging periods.
n R 7 stage 23–25 embryos per group; 37–63
neurons were analyzed per group. Kir-mCh cells,
hKir2.1-mCherry-expressing neurons; mCh cells,
mCherry-expressing neurons.
(D and E) VGluT1 and GABA staining and quanti-
tative analysis of stage 41 larvae from Kir-mCherry
DNA- and mCherry DNA-injected embryos.
Arrowheads identify a VGluT1-immunoreactive
and a GABA-immunoreactive neuron. n R 7 em-
bryos per group; 36–58 neurons were analyzed for
each group. VGluT1/mCherry and GABA/mCherry
represent the fraction of mCherry-labeled neu-
rons that are VGluT1-immunoreactive and GABA-
immunoreactive.
***p < 0.001; ns, not significant with Mann-Whitney
U test. See also Figure S1.
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fies transmitter identity, the network is likely to involve secreted
ligands that diffuse to receptors on neurons. Accordingly,
we plated different ratios of active (wild-type) and silenced
(hKir2.1-mCherry-labeled) neurons in dissociated cell cultures
(Figures 2A and 2B) and assessed the impact of diffusion of
agents among synaptically unconnected neurons. The results
indicate that the percent of neurons expressing GABA depends
on the percent of silenced hKir2.1-mCherry-expressing neurons
in the total population, as demonstrated by linear regression
analysis (Figure 2C): the slope is significantly nonzero (black).
In addition, assuming a linear relationship, the slopes are not
significantly different for active (wild-type, gray) and silenced
(hKir2.1-mCherry, red) neurons, further supporting a non-cell-
autonomous mechanism. We grouped the data into five classes
(0%, 25%, 50%, 75%, and 100% of silenced neurons) to
determine whether differences in percent of neurons expressing
GABA as a function of neurons expressing hKir2.1-mCherry
were significant (Figure 2D). We found that increasing the
percent of silenced neurons (hKir2.1-mCherry) leads to a pro-
gressive decrease in the percent of GABA-IR, further motivating
the search for a secreted ligand that regulates neurotransmitter
respecification.
BDNF Is Released by Ca2+ Spike Activity
Neurotrophins are important regulators of neural development,
survival, function, and plasticity (Chao, 2003). Neurotransmitter
specification in Xenopus embryos ismost responsive to changes
in Ca2+ spike activity during the critical period between neural1006 Neuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc.tube formation (stage 20) and an early larval stage (stage 28);
sensitivity decreases and disappears when the embryo ap-
proaches stage 35 (Borodinsky et al., 2004; Root et al., 2008).
BDNF expression has been detected in the neural plate in
Xenopus embryos at stage 18 (Huang et al., 2007).
In situ hybridization with a 387 base pair probe to BDNF re-
vealed its expression in the neural plate and neural tube at stages
18, 24, and 28, throughout the critical period for transmitter re-
specification when spontaneous Ca2+ spike activity is present
(Figure 3A). TrkB immunostaining identifies the presence of
BDNF receptors at stages 24 and 28 (Figure S2), sparsely ex-
pressed on a subset of neurons. To determine whether BDNF
is released by spike activity, we prepared nerve-muscle cultures
from embryos expressing BDNF-pHluorin (Matsuda et al., 2009).
Depolarization of neurons with KCl to mimic Ca2+ spikes (Gu and
Spitzer, 1995) stimulated Ca2+-dependent decreases in fluores-
cence (Figure 3B). A significant decrease was observed during
depolarization in the presence of 2 mM Ca2+ (13% ± 1%),
whereas no difference was observed during depolarization in
the absence of Ca2+ (1% ± 2%; Figure 3C). This result is consis-
tent with the changes in BDNF-pHluorin fluorescence observed
with substantial BDNF release (Matsuda et al., 2009). To
ascertain whether BDNF is released by spontaneous activity
throughout this critical period, we collected cell-conditioned cul-
ture medium before (1–3 hr in vitro), during (3–9 hr in vitro), and
after (14 hr in vitro) spontaneous Ca2+ spike activity (Chang
and Spitzer, 2009). Only cell-conditioned medium collected dur-
ing the period of spontaneous Ca2+ spike activity showed an in-
crease in the levels of released BDNF compared to the earlier
Figure 2. Increasing the Number of Silenced
Neurons In Vitro Decreases the Number of
Silenced and Active GABA-IR Neurons
Equally
(A and B) A representative view of active (wild-type)
and silenced (hKir2.1-mCherry labeled) neurons in a
dissociated 50% silenced neuron-enriched culture
(A). High-magnification views of individual active
or silenced neurons (B). Low-magnification view
showing two active and two silenced neurons
(arrowheads), one of which is GABA-IR+. hKir2.1-
mCherry: red; GABA-IR/hKir2.1-mCherry: yellow.
(C) The percent of neurons expressing GABA-IR
depends on the percent of silenced neurons ex-
pressing hKir2.1-mCherry. Black: total number of
GABA-IR neurons/total number of neurons. Red:
number of GABA-IR Kir+ neurons/number of Kir+
neurons. Grey: number of GABA-IR Kir neurons/
number of Kir neurons. Blue: total GABA-IR% of
100% silenced cultures with BDNF addition. Sim-
ple linear regression analysis was performed for
the first three groups. Total: slope = 0.19 ± 0.02,
significantly nonzero (p < 0.0001); Kir+: slope =0.15 ± 0.03, significantly nonzero (p < 0.0001); Kir: slope =0.14 ± 0.04, significantly nonzero (p = 0.002) with
use of ANOVA. The slopes for active (Kir) neurons, silenced (Kir+) neurons, and the total population are not significantly different with use of ANOVA.
(D) Bars represent the percent of neurons expressing GABA-IR from six groups (0%, 25%, 50%, 75%, 100% silenced and 100% silenced plus BDNF). Cultures
with more than 35 neurons poststaining were selected, and n = 4–8 cultures per group were analyzed.
Data are mean ± SEM. *p < 0.05; ***p < 0.001; ****p < 0.0001, with use of one-way ANOVA Tukey’s multiple comparisons test.
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BDNF-Dependent Transmitter Respecificationand later times when spontaneous Ca2+ spike activity is reduced
(Figure 3D). Moreover, a significant increase was observed in
cell-conditioned medium from control cultures when compared
to cell-conditioned medium obtained from cultures in which
Ca2+ spike activity had been suppressed by misexpression
of hKir2.1 mRNA. These results suggest that BDNF is released
in an activity-dependent manner. Strikingly, the decrease in
percent of GABA-IR neurons observed after the increase in
hKir2.1-mCherry expressing neurons in vitro (Figures 2C and
2D) is prevented when BDNF is applied to cultures of fully
silenced neurons. Based on these observations, we hypothe-
sized that BDNF regulates activity-dependent transmitter respe-
cification during early development.
BDNF Regulates Neurotransmitter Phenotype
Homeostatically
To examine the role of BDNF in the non-cell-autonomous mech-
anismof neurotransmitter respecification in vivo,we spatially and
temporally restricted production of BDNF by delivering a liss-
amine-tagged BDNF morpholino (BDNF MO) to the anterior spi-
nal cord by local electroporation at the neural plate stage (stage
15/16) to avoid early developmental defects caused by constitu-
tive inhibition (Figure 4A). Larvae from embryos electroporated
with a control MO (CMO) or BDNFMOwere fixed at 3 days (stage
41). The number of glutamatergic neurons was increased and
the number of GABAergic neurons was decreased in the anterior
spinal cord of embryos electroporated with BDNF MO (Figures
4C–4E), mirroring the effect of hKir2.1 misexpression in Xenopus
spinal neurons on transmitter respecification when Ca2+ spike
activity is blocked (Borodinsky et al., 2004).
We then implanted small agarose beads adjacent to the ante-
rior spinal cord to locally and chronically release BDNF during
specific stages of development (Borodinsky et al., 2004; Rootet al., 2008). Beads were loaded with BDNF or vehicle, implanted
at the time of neural tube closure (stage 18), and larvae were
fixed at stage 41 (Figure 4B). Embryos implanted with BDNF-
loaded beads showed an increase in number of GABAergic
neurons and a decrease in number of glutamatergic neurons
(Figures 4C–4E; Figure S3), mirroring the effect of rat brain
sodium channel II (Nav1.2a/b) misexpression in Xenopus spinal
neurons on transmitter respecification when Ca2+ activity is
enhanced (Borodinsky et al., 2004).
Activation of the TrkB receptor tyrosine kinase is the principal
pathway by which BDNF initiates downstream signaling. To
determine whether the observed effect of BDNF on transmitter
respecification was mediated by Trk receptors, we delivered
K252a, a membrane-permeable tyrosine kinase inhibitor with
relatively high affinity for TrkB receptors, via agarose beads im-
planted in embryos. As a negative control, we implanted em-
bryos with beads containing K252b, the nonfunctional analog
of K252a. As expected, the number of GABAergic neurons and
glutamatergic neurons in embryos implanted with K252b-loaded
beads was similar to that in controls with vehicle-loaded beads.
However, Trk inhibition with K252a had a similar effect to that
observed following electroporation of the BDNF MO (Figures
4D and 4E; Figure S3), suggesting that BDNF regulates trans-
mitter phenotype through a K252a-sensitive pathway, most
likely via TrkB receptor signaling.
To determine whether BDNF is an integration point for Ca2+
spike activity-dependent respecification of transmitters, we per-
formed simultaneous manipulations of Ca2+ activity and BDNF
in vivo. Misexpression of hKir2.1 mRNA to suppress Ca2+ spike
activity throughout the spinal cord generated an increase in the
number of glutamatergic neurons and a decrease in the number
of GABAergic neurons. Release of BDNF from beads implanted
adjacent to the spinal cord produced the opposite phenotypes.Neuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc. 1007
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Figure 3. BDNF Is Expressed throughout
the Critical Period for Neurotransmitter
Specification and Release Depends on
Spontaneous Ca2+ Spike Activity
(A) BDNF transcript expression in embryos at
stages 18, 24, and 28.
(B) BDNF release by Ca2+ spike activity. Left:
superimposed fluorescence and bright field im-
ages of a neuron andmuscle and undifferentiated
cells loaded with BDNF-pHluorin before and after
depolarization with 2 mM Ca2+ + 100 mM KCl
(2CaKCl). Right: representative trace showing
time course of cell body fluorescence changes of
a neuron and an undifferentiated cell. The culture
was first depolarized with KCl in the absence of
Ca2+ as control (0CaKCl), and then depolarized
three times in the presence of Ca2+ (2CaKCl).
Each 30 s depolarization, mimicking a Ca2+ spike,
causes a decrease in BDNF-pHluorin fluores-
cence selectively in the neuron in the presence of
Ca2+. Arrows indicate the start of perfusion: 0Ca,
0 mMCa2+ + 0.67 mM KCl; 0CaKCl, 0 mMCa2+ +
100mMKCl; 2Ca, 2mMCa2+ + 0.67mMKCl; and
2CaKCl, 2 mM Ca2+ + 100 mM KCl.
(C) Quantification of the decrease of BDNF-
pHluorin fluorescence in response to 2CaKCl.
n = 5 neurons from five independent experiments.
Data are mean ± SEM. **p < 0.01 with use of
Mann-Whitney U test.
(D) BDNF protein in culture medium in the
absence (Kir) or in the presence (control) of
spontaneous activity. Cultures were prepared
from embryos injected either with hKir2.1 mRNA
and cascade blue dextran or cascade blue dextran (control). Mediumwas collected at the indicated times and releasedBDNF levels (pg/ml) weremeasuredwith a
conventional two-site ELISA system. nR 4 cultures per condition;R 40 neurons/culture. Kir, hKir2.1 misexpression.
Data are mean ± SEM. *p < 0.05 with use of Mann-Whitney U test.
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BDNF in the spinal cord phenocopied the result obtained by
application of BDNF alone (Figures 4F and 4G). These results
indicate that Ca2+ spike activity regulates transmitter specifica-
tion upstream of BDNF function. Given the low frequency and
apparently stochastic generation of Ca2+ spikes, the non-cell-
autonomous coordination of Ca2+ spike activity and BDNF
derived from neighboring neurons may drive transmitter switch-
ing more reliably than cell-autonomous Ca2+ spike activity alone.
BDNF Regulates Neurotransmitter Fate via JNK-
Mediated cJun Phosphorylation
We next investigated the intracellular pathway regulated by
BDNF. Previous work identified cJun phosphorylation as the
Ca2+ spike entry point in the genetic pathway (Marek et al.,
2010). Because Ca2+ activity regulates phosphorylation of cJun
and BDNF is downstream of Ca2+ spikes, we first determined
whether BDNF regulates phosphorylation of cJun in vitro.
Western blotting of extracts from neuronal cultures with phos-
pho-specific antibodies showed that phosphorylation of cJun
(P-cJun) at serine 73 (S73) was decreased in response to Ca2+
spike suppression or in the absence of Ca2+ but was restored af-
ter BDNF application. In addition, K252a but not K252b blocked
the effect of Ca2+ spikes on cJun phosphorylation (Figure 5A),
and immunostaining of the embryonic spinal cord (stage 28)1008 Neuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc.revealed that TrkB is expressed in the same subset of neurons
showing cJun phosphorylation (Figure 5B), suggesting that
BDNF-induced cJun phosphorylation is mediated by TrkB re-
ceptor signaling.
To confirm these results in vivo, we examined S73 cJun phos-
phorylation after BDNF manipulation. Embryos were electropo-
rated with BDNF MO at the neural plate stage (stage 15/16) or
implanted with BDNF-loaded beads at the time of neural tube
closure (stage 18), fixed at 1.5 days of age (stage 28), sectioned,
and immunostained.BDNF-treated embryos showedan increase
in the number of cells exhibiting cJun phosphorylation (14% to
28% of total cells expressing cJun), whereas the opposite effect
was found when BDNF function was knocked down by morpho-
lino electroporation (14% to 7% of total cells expressing cJun;
Figure 5C). This result is consistent with the previous demonstra-
tion of decreased phosphorylation of cJun in response to Ca2+
spike suppression and increased phosphorylation in response
to Ca2+ spike enhancement (Marek et al., 2010). No changes
wereobserved in the number of cells expressing cJun (Figure 5D).
To identify the signaling components downstream of BDNF
leading to changes in cJun phosphorylation, we turned again
to neuronal cultures. A pharmacological screen was used to
determine which drugs reduce the level of phosphorylated
cJun detected bywestern blots of protein extracts from neuronal
cultures in which Ca2+ activity is present. BDNF stimulates
AC
D
F G
E
B Figure 4. BDNF Regulates Neurotransmitter
Phenotype Downstream of Ca2+ Spike
Activity
(A) Embryos were electroporated with lissamine-
tagged BDNF MO or CMO. Lissamine distribution
(red) in a live stage 41 larva demonstrates targeting
of the spinal cord.
(B) Single agarose beads (blue) loaded with BDNF,
K252a, or K252b were implanted adjacent to the
nascent neural tube (white dashed circle) at stage
19 and stage 41 larvae were sectioned for immu-
nocytochemistry.
(C–E) GABA (C and D) and glutamate (C and E)
staining following implantation of beads con-
taining BDNF (100 ng/ml), K252a or K252b (50 mM),
a membrane-impermeable analog of K252a, or
BDNF MO and CMO electroporation. Beads were
located adjacent to the most rostral 100 mm of the
spinal cord; nR 5 embryos per condition; 101–195
neurons were analyzed per condition per 200 mm.
(F and G) GABA and glutamate expression in em-
bryos in the presence of BDNF (C–E), in embryos
misexpressing hKir2.1, and in embryos misxpress-
ing hKir2.1 in the presence of BDNF. nR 5 embryos
per condition; 128–255 neurons were analyzed per
condition per 200 mm.
Data are mean ± SEM. *p < 0.05; **p < 0.01. ns, not
significant. ANOVA test with Bonferroni post hoc
analysis was used. See also Figure S2.
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D
B Figure 5. BDNF Regulates cJun Phosphory-
lation
(A) P-cJun expression in the presence or absence
of hKir2.1 expression, BDNF (100 ng/ml) or Trk
receptor blocker (50 mM). Protein levels in neuronal
cultures were determined by western blot. Graph
presents the ratio between the phosphorylated
protein and total protein expressed in optical
density units (ODU). nR 5 cultures per condition.
Kir, hKir2.1 misexpression. Full-length western
blot is shown in Figure S5.
(B) P-cJun and TrkB staining of embryos (stage 28)
showing colocalization. n R 5 embryos per con-
dition; 132–151 neurons were analyzed per con-
dition per 100 mm.
(C and D) P-cJun (C) and cJun (D) staining of em-
bryos (stage 28) in the presence of control or
BDNF beads or electroporated with BDNF MO or
CMO. n R 5 embryos per condition; 137–158
neurons were analyzed per condition per 100 mm.
Data are mean ± SEM. *p < 0.05; **p < 0.01 with
use of Mann-Whitney U test.
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TrkB receptors (Huang and Reichardt, 2003). We first assessed
the role of MAPK inhibitors to characterize the kinase that phos-
phorylates cJun. cJun can be phosphorylated by MAPKs such
as JNK, p38, and ERK1/2. Accordingly, we used SP600125 to
inhibit JNK, U0126 to inhibit ERK1/2 (MEK), and SB235699 to
inhibit p38. Western blot assays demonstrated that inhibiting
JNK and MEK, but not p38, causes a significant decrease in
cJun phosphorylation (Figure S4).
Because Ca2+ activity could be involved, we tested inhibitors
for the Ca2+-dependent kinases PKC (GF109203x) and CAMKII
(KN-93). To determine whether TrkB/MAPK signaling is the prin-
cipal pathway responsible for cJun phosphorylation, we tested
inhibitors for the PI3K (LY294002) and PLCg (U73122) pathways.
Western blot assay showed that phosphorylation of cJun was
not decreased in response to any of these inhibitors (Figure S4),
suggesting that the TrkB-activated MAPK signaling pathway is
responsible for cJun phosphorylation.
To further test the participation ofMAPK in BDNF signaling, we
performed western blot assays on cultures following Ca2+ spike
suppression and BDNF addition. Both MEK and JNK inhibitors
reduced cJun phosphorylation mediated by BDNF (Figure 6A).
JNK is an attractive candidate because it can regulate cJun ac-
tivity via direct phosphorylation of cJun S63/S73 and T91/T931010 Neuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc.(Raivich, 2008) and its expression has
been detected in the head and the dorsal
region of stage 24 embryos by both RT-
PCR and in situ hybridization (Yamanaka
et al., 2002).
To determine whether BDNF acti-
vates JNK in vivo to phosphorylate cJun,
we examined JNK phosphorylation after
BDNF manipulation. Embryos were elec-
troporatedwith the BDNFMOor implanted
with BDNF-loaded beads, in separate ex-
periments, fixed at stage 28, sectioned,and immunostained to examine JNK activation. BDNF-treated
embryos showed an increase in the number of cells exhibiting
JNK phosphorylation whereas the opposite effect was found
when BDNF function was knocked down by MO electroporation
(Figure 6B), suggesting that the BDNF-induced signaling
pathway leads to JNK activation. No changes were observed
in the number of cells expressing JNK (Figure 6C). Consistent
with western blot results, in vivo electroporation of a JNK MO
blocked the increases in P-cJun-IR (Figure 7A), mimicking the
effect of the BDNF MO described above and suggesting that
JNK has a primary role in the BDNF-induced signaling pathway
leading to cJun phosphorylation. No changes were observed
in the number of cells expressing cJun (Figure 7B). Moreover,
the JNK MO blocked the increase in GABA-IR and the decrease
in glutamate-IR otherwise stimulated by misexpression of
Nav1.2a/b that increases Ca2+ spike activity (Figures 7C and
7D). Thus, BDNF regulates transmitter respecification by modu-
lating JNK-mediated cJun phosphorylation via a TrkB/MAPK
signaling pathway.
DISCUSSION
Regulation of the levels of an existing neurotransmitter has
been well characterized, but the molecular signaling involved in
AB
C
Figure 6. Signaling Pathway Regulating
BDNF-Dependent cJun Phosphorylation
(A) P-cJun expression in the presence or absence
of BDNF (100 ng/ml) and inhibitors of ERK1/2
(MEK, U0126), JNK (SP600125), or Trk receptors
(K252a; all 10 mM). Graph as in Figure 5. n R 5
cultures per condition;R 40 neurons/culture. Data
are mean ± SEM. *p < 0.05 with use of ANOVA test
with Bonferroni post hoc analysis. Full-length
western blot is shown in Figure S5.
(B and C) P-JNK (B) and JNK (C) staining of em-
bryos in the presence of control or BDNF beads or
electroporated with BDNF MO or CMO. n R 5
stage 28 embryos per condition; 137–151 neurons
were analyzed per condition per 100 mm. Data are
mean ± SEM. *p < 0.05 with use of Mann-Whitney
U test.
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BDNF-Dependent Transmitter Respecificationtransmitter respecification initiated by activity has received little
attention. Increases or decreases in Ca2+ spike activity during
development of the Xenopus nervous system lead to changes
in transmitter specification that are generally compensatory
and homeostatic. Here we have developed a practical method
to manipulate Ca2+ activity in single neurons in vivo to determine
whether changes are triggered by alteration of activity in single
neurons. Our results indicate that suppression of activity in single
spinal neurons is not sufficient to trigger changes in transmitters,
identifying the role of a non-cell-autonomous mechanism.
Graded suppression of activity in an increasingly large fraction
of a neuronal population led to a graded change in the number
of neurons expressing GABA, with no difference between
silenced and active neurons. We then demonstrated that Ca2+
spike activity generated prior to synapse formation acts via
BDNF through a TrkB/MAPK signaling pathway to phosphory-
late cJun and respecify transmitter phenotype. These results
identify a molecular cascade that transduces electrical activity
into a switch in transmitter identity.Neuron 82, 1004–1Silencing Single Neurons In Vivo and
Graded Populations In Vitro
Although delivery of genes to single cells
in vivo is conceptually and experimentally
attractive, it has been challenging to
implement due to technical difficulties.
Single-cell gene targeting is useful to
determine whether the effects induced
by exogenous or endogenous gene
expression in the targeted cell are cell
autonomous or due to interactions with
neighboring cells. In Drosophila, homozy-
gous mutant cells have been targeted for
mosaic analysis by placing a repressible
cell marker (MARCM) in trans to a mutant
gene of interest using FLP/FRT-mediated
mitotic recombination (Lee and Luo,
1999). In mice, the Cre/loxP system has
been applied to develop a method for
mosaic analysis with double markers
for simultaneous labeling and mutation ofneurons (Zong et al., 2005). These genetic methods are efficient
in labeling small populations of neurons and even single cells
in small or inaccessible embryos when blastomere injection is
not an option.
Ca2+ spike frequency homeostatically regulates respecifica-
tion of transmitters in the spinal cord during a brief critical period
(Borodinsky et al., 2004; Root et al., 2008). The number of neu-
rons in which transmitter switching occurs is modest, both
because the number of primary neurons is small (Hartenstein,
1993) and because some neurons do not demonstrate trans-
mitter respecification (Borodinsky et al., 2004; Dulcis and Spit-
zer, 2008; Dulcis et al., 2013). We determined whether the effect
on transmitter switching induced by Ca2+ spike activity occurs
via a cell-autonomous mechanism by targeting single neurons
efficiently with foreign gene (hKir2.1) expression in Xenopus at
early developmental stages. Injection of this DNA into specific
blastomeres of 16-cell-stage embryos drives its expression in
a mosaic pattern in spinal neurons and suppresses spike activity
in these neurons. Suppression of Ca2+ spikes in single neurons016, June 4, 2014 ª2014 Elsevier Inc. 1011
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Figure 7. JNK Regulates cJun Phosphoryla-
tion and Neurotransmitter Phenotype
(A and B) P-cJun (A) and cJun (B) staining of em-
bryos (stage 28) electroporated with JNK MO or
CMO; 128–152 neurons were analyzed per condi-
tion per 100 mm.
(C and D) GABA (C) and glutamate (D) staining of
embryos (stage 41) following JNK MO and CMO
electroporation. nR 5 embryos per condition; 152–
215 neurons were analyzed per condition per
200 mm.
Data are mean ± SEM. *p < 0.05 with use of Mann-
Whitney U test.
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BDNF-Dependent Transmitter Respecificationdid not result in an increase in incidence of glutamate expression
or a decrease in the incidence of GABA expression, providing
evidence for non-cell-autonomous regulation. The absence of
transmitter switching is unlikely to be due to delay of the normal
process, because it was assayed well beyond the end of the crit-
ical period, when neurotransmitter in each subtype of neuron has
been determined (Root et al., 2008). Cholinergic motorneurons
demonstrate coactivity across the spinal cord at these early
stages, enabling motorneurons on a silenced half of the spinal
cord to receive excitation from motorneurons on an unsilenced
half of the spinal cord, consistent with the observation that
only bilateral and not unilateral silencing of activity is sufficient1012 Neuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc.to switch the cholinergic phenotype (Bor-
odinsky et al., 2004). However, synchro-
nized activity does not appear to be a
general feature of these differentiating
neurons. In contrast, glutamatergic and
GABAergic neurons, which lack compa-
rable synaptic excitation at this stage of
development, exhibit transmitter switch-
ing in a silenced half of the spinal cord
(Borodinsky et al., 2004).
Consistent with this result, a progres-
sive increase in the percent of silenced
neurons in culture leads to a progressive
decrease in the percent of neurons ex-
pressing GABA, equally in active and in
silenced neurons. Thus, the transmitter
switches observed following global spike
suppression in the entire spinal cord
result from a non-cell-autonomous pro-
cess. A key determinant appears to be
the activity of surrounding neurons, rather
than the activity level of the target neuron
itself.
Role of BDNF in Balancing
Neurotransmitter Specification
BDNF appears to be a differentiation
factor for most neurons (Park and Poo,
2013). It stimulates formation andmatura-
tion of inhibitory GABAergic neurons and
synapses (Ohba et al., 2005) and sup-presses excitatory synaptic transmission (Yang et al., 2002).
Adult glutamatergic hippocampal granule cells in culture coex-
press a GABAergic phenotype when incubated in the presence
of BDNF (Go´mez-Lira et al., 2005). BDNF increases the number
and density of GABAergic synapses in solitary neurons cultured
from rat visual cortex (Palizvan et al., 2004) and in hippocampal
neurons in vivo (Shinoda et al., 2011). Exogenous BDNFprevents
the enhancement of synaptic strengths normally induced by
chronic blockage of activity in cortical cultures. Furthermore,
preventing activation of endogenous BDNF receptors mimics
the effects of activity blockade and increases synaptic strengths
(Rutherford et al., 1998).
Figure 8. Model of Non-Cell-Autonomous Regulation of Transmitter
Expression
Transmitter identity is initially specified genetically and then modulated by
environmental influences through changes in spontaneous Ca2+-dependent
activity. Ca2+ spikes regulate the release of BDNF that initiates the TrkB/MAPK
signaling cascade. JNK-mediated phosphorylation of cJun regulates tran-
scription to select neurotransmitter fate.
Neuron
BDNF-Dependent Transmitter RespecificationOur results indicate that BDNF is released from neurons in a
Ca2+ spike activity-dependent manner and that BDNF regulates
activity-dependent transmitter respecification. GFAP immunore-
activity is detected in radial cells in the neural tube as early as
stage 24 (Szaro and Gainer, 1988) and GFAP-positive cells can
express BDNF (Dreyfus et al., 1999; Abe et al., 2010); further
studies will be needed to determine whether glia release BDNF
in an activity-dependent or independent manner. An activity-in-
dependent BDNF source may be responsible for the release of
BDNF observed after activity suppression. Activity-dependent
release of BDNF increased the number of GABAergic neurons
in the spinal cord in agreement with demonstration that BDNF
scales up inhibitory neuronal networks; it decreased the number
of glutamatergic neurons consistent with scaling down excit-
atory neuronal networks.
BDNF Signaling in Ca2+ Activity-Dependent
Neurotransmitter Switching
BDNF appears to regulate transmitter respecification via TrkB
receptors, because the effects of a BDNF MO and K252a on
the incidence of glutamatergic and GABAergic neurons were
indistinguishable. The sparse expression of TrkB receptors, on
a subset of cells, is consistent with transmitter switching in a
subset of neurons. Interestingly, the neurons expressing TrkB
receptors are the same neurons presenting the activated cJun
pathway. They are distributed throughout the spinal cord and
do not appear to constitute a previously identified class of neu-
rons. BDNF could stimulate PLCg, PI3K, and MAPK signaling
pathways via activation of TrkB receptors (Huang and Reichardt,
2003). However, we found that the MAPK pathway, but not the
PI3K or the PLC-g pathways, regulated the phosphorylation of
cJun by BDNF via MEK and JNK. BDNF preferentially activates
MEK but may also activate JNK (Chao, 2003) and there is cross-
talk between these two signaling pathways (Dong and Bode,2003). JNK regulates cJun activity via direct phosphorylation
of S63/S73 and T91/T93 (Raivich, 2008) andMEK can also phos-
phorylate cJun S63/S73 via ERK 1/2 (Morton et al., 2003). Both
MEK and JNK signaling had a role in cJun phosphorylation;
whether they act in series or in parallel pathways remains to
be determined. BDNF caused an increase in JNK phosphoryla-
tion that was correlated with an increase in cJun activation,
because both the JNKMOand BDNFMOdecreased cJun phos-
phorylation similarly. The number of P-cJun-IR neurons is small
at each time point but it is likely that the total number is larger.
Because the data are snapshots in time, they do not reveal the
total number of neurons showing P-cJun during the period of
Ca2+ spiking. P-cJun acts as a Ca2+ spike-dependent repressor
of the homeobox gene tlx3 that functions as a switch specifying
the glutamatergic over GABAergic phenotype in Xenopus
(Marek et al., 2010). Consistent with this action, the percentage
of neurons expressing P-cJun is similar to the percentage of
GABAergic neurons in the absence or presence of BDNF,
suggesting that they are linked. Direct double staining of
P-cJun and GABA or glutamate is not possible because the
former has disappeared by the time the latter appears. The
JNK MO mimicked the effect of the BDNF MO on the numbers
of P-cJun-, GABA-, and glutamate-IR neurons, suggesting
that JNK signaling pathway activation is sufficient to phos-
phorylate cJun and lead to BDNF-induced transmitter
switching. Determination of the molecular cascade by which
activity drives transmitter respecification is essential for devel-
opment of the tools with which to gain control over transmitter
changes.
Model for Non-Cell-Autonomous Regulation of
Transmitter Switching
Neuronal activity plays an important role in regulating many
properties of neurons, including neuronal migration and synaptic
plasticity, either cell autonomously (Burrone et al., 2002; Tong
et al., 2009) or non-cell autonomously (Hartman et al., 2006;
Wright and Ribera, 2010). We propose a model for non-cell-
autonomous Ca2+ spike activity-mediated homeostatic trans-
mitter respecification in Xenopus spinal neurons during early
stages of development (Figure 8). Transmitter identity is initially
specified genetically and then modulated by environmental
influences through changes in spontaneous Ca2+-dependent
activity. Ca2+ spikes regulate the release of BDNF that initiates
the TrkB/MAPK signaling cascade. This cascade involves JNK-
mediated phosphorylation of cJun that regulates tlx3 transcrip-
tion through a CRE site in its promoter (Marek et al., 2010).
Parallel pathways may be involved to ensure that the correct
transmitter phenotype is established and maintained throughout
development. The integration of activity and genetic programs
provides a better understanding of transmitter switching and
may also provide insights into the pathogenesis of neurological
disorders, such as depression, to which environmental stimuli
contribute and in which transmitter expression is altered.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Experi-
mental Procedures. All animal procedures were performed in accordanceNeuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc. 1013
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BDNF-Dependent Transmitter Respecificationwith institutional guidelines and approved by the UCSD Institutional Animal
Care and Use Committee.
Blastomere Injection
DNA injection (1 nl of 0.2 mg/ml hKir2.1-mCherry-pcDNA3.1 or mCherry-
pcDNA3.1) was performed at the 16-cell stage in specific blastomeres
identified according to Moody (1989). RNA injection (5–10 nl of 0.01–
0.1 mg/ml hKir2.1 or BDNF-pHluorin with 10,000 molecular weight 20 mg/
ml cascade blue dextran) was performed at either the 2- or 16-cell stage.
Injections were accomplished using a picospritzer (Picospritzer III, Parker
Instrumentation).
Calcium Imaging
Stage 23–25 embryos were dissected as previously described (Gu et al.,
1994). Briefly, neural tubes were pinned to expose the ventral surface and
loaded for 45 min with 5 mM of the Fluo-4 AM Ca2+ indicator (Invitrogen) and
0.01% Pluronic F-127 detergent (Invitrogen) in 2 mM Ca2+ saline. Images
were acquired at 0.2 Hz for 1 hr periods with a Leica SP5 confocal system
and Ca2+ transients were scored as spikes when the rise time was complete
within 5 s and the amplitude exceeded 20% of DF/F0, more than twice
the standard deviation of the baseline during the previous 10 min. Seven
to ten embryos were imaged for each experiment. All hKir2.1-mCherry- or
mCherry-expressing single neurons from these embryos were analyzed. Neu-
rons not expressing hKir2.1-mCherry or mCherry in the same embryos were
internal controls. The incidence of spiking neurons from each experimental
group was calculated by dividing the number of neurons that spiked at least
once during the 1 hr imaging period by the total number of neurons analyzed
in that group.
Immunocytochemistry
Immunocytochemistry was performed as previously described (Borodinsky
et al., 2004; Marek et al., 2010). Further information is provided in the Supple-
mental Experimental Procedures.
Cell Culture
Neuron-enriched cultures were prepared from the posterior neural plate of
stage 15 X. laevis embryos as previously described (Gu et al., 1994). Details
can be found in the Supplemental Experimental Procedures.
Graded Expression of Activity
Embryos were injected with 0.6 mg/ml hKir2.1-mCherry mRNA at the one- or
two-cell stage and neuron-enriched cultures were prepared at stage 15 with
0%, 25%, 50%, 75%, or 100% silenced neurons. Graded silencing was
achieved by mixing cells from neural plates of embryos expressing hKir2.1
differentially. For example, 75% silencing was achieved by plating half of a
neural plate from an embryo expressing hKir2.1 unilaterally with half of a neural
plate from an embryo expressing hKir2.1 bilaterally. For the rescue experi-
ment, recombinant BDNF (100 ng/ml, Chemicon Millipore) was added to
cultures with 100% silenced neurons. Cultures were fixed with 4%paraformal-
dehyde with 0.1% glutaraldehyde at 1 day in vitro and immunostained for
GABA. Cultures with more than 35 neurons poststaining were selected and
the percentages of neurons singly and doubly labeled for GABA-IR and
hKir2.1-mCherry were scored.
Whole Mount In Situ Hybridization
Whole mount in situ hybridization was performed (Harland, 1991) using
antisense and sense probes generated from pX112-13 containing a partial
Xenopus BDNF cDNA (a generous gift from Dr. Susana Cohen-Cory, UC
Irvine). Details are provided in the Supplemental Experimental Procedures.
Time-Lapse Imaging of BDNF-pHluorin
Ca2+ spike-dependent BDNF release was assayed in cultures prepared from
embryos injected with BDNF-phluorin mRNA at the 16-cell stage and grown
in 0 mM Ca2+ medium for 9–12 hr. Cultures were mounted in a custom-
made chamber, perfused with salines containing 100 mM KCl in the absence
or presence of 2 mM Ca2+ for 30 s to mimic Ca2+ spikes as previously
described (Gu and Spitzer, 1995), and imaged on a Leica SP5 confocal micro-1014 Neuron 82, 1004–1016, June 4, 2014 ª2014 Elsevier Inc.scope with 633water-immersion objective. Time-lapse images were acquired
at 1.29 s intervals. Cell body fluorescence intensity of BDNF-pHluorin-ex-
pressing neuronswas quantified using ImageJ and normalized by nonneuronal
cells in the same fields.
BDNF Immunoassay
BDNF released under different conditions was measured with a conventional
two-site ELISA system according to the manufacturer’s protocol (Promega).
Morpholino Electroporation
Local electroporation was performed on stage 15/16 embryos, 18 hr post-
fertilization, using a protocol based on the method developed by Sasagawa
et al. (2002). Embryos were placed on an agarose bed over a circular plat-
inum anode (20 mm in diameter; NEPA GENE) in a 13 Marc’s Modified
Ringer’s solution to decrease the resistance between the two electrodes.
We targeted the region of interest identified by a map of presumptive spinal
cord region of the neural tube of stage 15 embryos (Eagleson and Harris,
1990) with the BDNF MO, JNK MO, or a control MO. Morpholino solutions
(5 nl of 0.25 mg/ml) were injected into the presumptive spinal cord region of
the closing neural tube. A platinum wire cathode (0.5 mm diameter; Sigma)
was placed over the region of interest immediately after injection and a Grass
stimulator was used to deliver six square pulses of 5 ms, 40 V, at 500 ms in-
tervals. Electroporated embryos were transferred to 10% Marc’s Modified
Ringer’s solution and maintained at 18C to slow development, promote
healing, and allow a longer period of action. Nonelectroporated embryos
grown in the same conditions served as controls. Larvae with lissamine
fluorescence extending over a region of 400 mm encompassing the anterior
spinal cord were analyzed at stage 41, approximately 5 days after
electroporation.
Pharmacology
Agarose beads (100–200 mesh, Bio-Rad) were loaded overnight with drugs
(50 mM K252a, K252b; 100 ng/ml BDNF) or DMSO/H2O (control) and inserted
between the neural tube and myotomes at 20 hr of development (stage 18;
Borodinsky et al., 2004; Root et al., 2008). Sections of embryos with beads
located adjacent to the first 100 mm of the spinal cord were collected 2 days
later (stage 41). Changes in both GABA and glutamate expression in spinal
neurons were significant along all 400 mm of the rostral spinal cord in
K252a bead-implanted embryos, consistent with the small size of K252a
(0.4 kD) enabling diffusion. Changes in both GABA and glutamate expression
were significant only over the first 100 mm from the BDNF-loaded bead,
consistent with limited diffusion of recombinant BDNF (27 kD). Stock con-
centrations of kinase inhibitors SP600125, SB235699, U0126, KN-93, GF
109203x, LY294002, and U73122 (Tocris Bioscience) were 10 mM in
DMSO and were added to the culture medium as indicated. Stock con-
centrations of drugs were 1 mM K252a (Sigma-Aldrich) and 1 mM K252b
(Sigma-Aldrich) in DMSO, and 1 mg/ml recombinant BDNF (Millipore) in
distilled water.
Statistics
Means and SEMs were calculated using Microsoft Excel. Statistical analyses
were performed using STATA. For comparisons amongmore than two groups,
the ANOVA test was used and followed by Bonferroni post hoc test. For com-
parisons between two groups, the Mann-Whitney U test was used. Values
were considered as significantly different at p < 0.05.
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